Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran
- PMID: 35169997
- PMCID: PMC8853202
- DOI: 10.1007/s11033-022-07225-3
Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran
Abstract
Background: This study was aimed to evaluate the antibiotic resistance, biofilm formation, and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa (CRPA) strains isolated from four types of nosocomial infections (NIs) including urinary tract infection (UTI), ventilator-associated pneumonia (VAP), surgical site infection (SSI), and bloodstream infection (BSI).
Methods and results: In total, 115 isolates of NIs-causing P. aeruginosa were collected from NIs. Antibiotic susceptibility testing (AST) was performed using disk diffusion method and minimum inhibitory concentrations. Biofilm formation was tested on 96-well polystyrene microtiter plates (MTP). CRPA isolates were genotyped using multiple-locus variable number of tandem repeat analysis (MLVA). The most resistance and susceptibility rates were observed to amikacin (70.6%) and colistin (96.1%), respectively. Colistin and meropenem were the most active antimicrobial agents in VAP, SSI, and BSI. While, colistin and cefepime were the most active in UTIs. In total, 52.2% (n = 60/115) of P. aeruginosa isolates were carbapenem resistant, of which 95.0%, 55.0%, and 5.0% were multidrug-resistant, extensively drug-resistant, and pandrug-resistant, respectively. There was a significant association between resistance to carbapenem and resistance to other antibiotics except for piperacillin/tazobactam. The biofilm production of CRPA isolates was 95.0%, of which 23.3% were strong biofilm producers. Based on MLVA, there were 34 different types of CRPA isolates classified into three main clusters and 5 sub clusters.
Conclusion: The association of CRPA with other antibiotic resistance, the high rates of biofilm production, and the high genetic diversity of the isolates may be a warning of the need for a careful surveillance program.
Keywords: Antibiotic resistance; Biofilm; MLVA; Nosocomial infections; Pseudomonas aeruginosa.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
The authors have no conflict of interest.
Figures


Similar articles
-
Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.J Clin Lab Anal. 2023 Apr;37(4):e24850. doi: 10.1002/jcla.24850. Epub 2023 Feb 17. J Clin Lab Anal. 2023. PMID: 36808649 Free PMC article.
-
Critical resistance to carbapenem and aminoglycosides in Pseudomonas aeruginosa: spread of blaNDM/16S methylase armA harboring isolates with intrinsic resistance mechanisms in Kerman, Iran.BMC Infect Dis. 2024 Oct 21;24(1):1188. doi: 10.1186/s12879-024-10085-w. BMC Infect Dis. 2024. PMID: 39434025 Free PMC article.
-
Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).Infect Genet Evol. 2020 Nov;85:104518. doi: 10.1016/j.meegid.2020.104518. Epub 2020 Sep 4. Infect Genet Evol. 2020. PMID: 32891877
-
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms.Curr Opin Infect Dis. 2024 Dec 1;37(6):594-601. doi: 10.1097/QCO.0000000000001044. Epub 2024 Sep 18. Curr Opin Infect Dis. 2024. PMID: 39149832 Free PMC article. Review.
-
Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.mSphere. 2021 May 19;6(3):e00202-21. doi: 10.1128/mSphere.00202-21. mSphere. 2021. PMID: 34011686 Free PMC article. Review.
Cited by
-
Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models.Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0057823. doi: 10.1128/aac.00578-23. Epub 2023 Oct 19. Antimicrob Agents Chemother. 2023. PMID: 37855639 Free PMC article.
-
Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis.Front Microbiol. 2024 Oct 9;15:1477836. doi: 10.3389/fmicb.2024.1477836. eCollection 2024. Front Microbiol. 2024. PMID: 39473844 Free PMC article.
-
Proportions of Pseudomonas aeruginosa and Antimicrobial-Resistant P aeruginosa Among Patients With Surgical Site Infections in China: A Systematic Review and Meta-analysis.Open Forum Infect Dis. 2023 Dec 18;11(2):ofad647. doi: 10.1093/ofid/ofad647. eCollection 2024 Feb. Open Forum Infect Dis. 2023. PMID: 38328500 Free PMC article.
-
Investigation of the Antibacterial Effectiveness of Hybrid Recombinant Bacteriocins Circular Enterocin and Pyocin L1 Derived from Pseudomonas aeruginosa and Enterococcus faecalis.Biochem Genet. 2025 Jun 13. doi: 10.1007/s10528-025-11149-5. Online ahead of print. Biochem Genet. 2025. PMID: 40512297
-
Diagnosis of Bloodstream Infections: An Evolution of Technologies towards Accurate and Rapid Identification and Antibiotic Susceptibility Testing.Antibiotics (Basel). 2022 Apr 12;11(4):511. doi: 10.3390/antibiotics11040511. Antibiotics (Basel). 2022. PMID: 35453262 Free PMC article. Review.
References
-
- Labovská S. Pseudomonas aeruginosa as a cause of nosocomial infections. Pseudomonas aeruginosa-biofilm formation, infections and treatments IntechOpen. 2021 doi: 10.5772/intechopen.9590. - DOI
-
- Mohammadi M, Vaisi Raiegan A, Jalali R, Ghobadi A, Salari N, Barati H. The prevalence of nosocomial infections in Iranian hospitals. J Babol Uni Med Sci. 2019;21:39–45.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources